Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Order Your Article Before Print

Ranking and Category

  • 131st of 267 in

    Pharmacology & Pharmacy

In the current Pandemic scenario, all articles related to Coronavirus will be processed on a free, quick track basis, to ensure timely review and publication of much needed research

Articles Ahead of Print

The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer

Linqi Yang, Wenqi Zhang, Saiyam Chopra, Deeepjyot Kaur, Huibing Wang, Meng Li, Pingping Chen* and Wei Zhang

DOI: 10.2174/1389450121666200504080112
View Abstract View on PubMed

Acetaminophen Oxidation And Inflammatory Markers – A Review From Hepatic Molecular Mechanisms And Preclinical Studies

Silvio Terra Stefanello, Nelson Rodrigues de Carvalho, Simone Beder Reis, Felix Alexandre Antunes Soares and Rômulo Pillon Barcelos*

DOI: 10.2174/1389450121666200510014418
View Abstract

Anti-VEGF and Retinal Dystrophies

Maurizio Battaglia Parodi, Pierluigi Iacono* and Stefano Da Pozzo

DOI: 10.2174/1389450121666200428103334
View Abstract View on PubMed

Exosomes in Inflammatory Bowel Disease: What We Learnt So Far?

Haichao Wang, Chen Ye, Yaling Wu, Pengyu Yang, Chunqiu Chen, Zhanju Liu and Xiaolei Wang*

DOI: 10.2174/1389450121666200428102330
View Abstract

PD1/PD-L1 Axis in Uro-oncology

Kerstin Junker*, Markus Eckstein, Michelangelo Fiorentino and Rodolfo Montironi

DOI: 10.2174/1389450121666200326123700
View Abstract View on PubMed

Anti-VEGF Treatment in Corneal Diseases

Giuseppe Giannaccare, Marco Pellegrini, Cristina Bovone, Rossella Spena, Carlotta Senni, Vincenzo Scorcia and Massimo Busin*

DOI: 10.2174/1389450121666200319111710
View Abstract View on PubMed

PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: The Role of PD-L1 Assay

Alessia Cimadamore*, Francesco Massari , Matteo Santoni, Antonio Lopez-Beltran , Liang Cheng , Marina Scarpelli, Rodolfo Montironi and Holger Moch

DOI: 10.2174/1389450121666200324151056
View Abstract View on PubMed

Immunotherapy and Radiation Therapy in Renal Cell Carcinoma

Veronica Mollica, Matteo Santoni, Vincenzo Di Nunno, Alessia Cimadamore, Liang Cheng, Antonio Lopez-Beltran, Nicola Battelli, Rodolfo Montironi and Francesco Massari*

DOI: 10.2174/1389450121666200311121540
View Abstract View on PubMed

Challenges with Wound Infection Models in Drug Development

Sandeep K Shukla*, Ajay K Sharma, Vanya Gupta, Aman Kalonia and Priyanka Shaw

DOI: 10.2174/1389450121666200302093312
View Abstract View on PubMed

Aromatase Inhibitors for Ovarian Stimulation in Patients with Breast Cancer

Esteban Ferreiro , Belén López de Uralde , Rita Abreu , Juan A García-Velasco and Elkin Muñoz *

DOI: 10.2174/1389450121666200220124607
View Abstract View on PubMed

Is Galanin a Promising Therapeutic Resource for Neural and Nonneural Diseases?

Caroline Maria Oliveira Volpe, Tatiana Vaz, Fabiana Rocha-Silva, Pedro Henrique Villar-Delfino and José Augusto Nogueira-Machado*

DOI: 10.2174/1389450121666200225112055
View Abstract View on PubMed

ACE2/Angiotensin-(1-7)/Mas Receptor Axis in Human Cancer: Potential Role for Pediatric Tumors

Ana Luiza Ataide Carneiro de Paula Gonzaga , Vitória Andrade Palmeira , Thomas Felipe Silva Ribeiro , Larissa Braga Costa , Karla Emília de Sá Rodrigues and Ana Cristina Simões-e-Silva *

DOI: 10.2174/1389450121666200210124217
View Abstract View on PubMed

The Potential of PI3K/AKT/mTOR Signaling as a Druggable Target for Endometrial and Ovarian Carcinomas

Csongor György Lengyel*, Sara Cecilia Altuna, Baker Shalal Habeeb, Dario Trapani and Shah Zeb Khan

DOI: 10.2174/1389450120666191120123612
View Abstract View on PubMed

Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer

Adrian Bartoszek, Jakub Fichna*, Aleksandra Tarasiuk, Agata Binienda, Adam Fabisiak, Julia B. Krajewska, Paula Mosińska, Karolina Niewinna and Maciej Salaga

DOI: 10.2174/1389450120666191112141901
View Abstract View on PubMed

Exploring the Clinical Impact of Predictive Biomarkers in Serous Ovarian Carcinomas

Cécile Le Page*, Jacqueline Chung, Kurosh Rahimi, Martin Kobel, Diane Provencher and Anne-Marie Mes-Masson

DOI: 10.2174/1389450120666191016143836
View Abstract View on PubMed


Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63



Related Journals

Related eBooks

eBooks Catalog